XYLOCARD 50 mg/ml, solution for infusion 10 bottles of 20 ml
Active ingredients: Lidocaine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Solution for infusion10 bottles of 20 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- XYLOCARD 50 mg/ml, solution injectable pour perfusion
- Pharmaceutical form
- solution injectable pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 flacon(s) en verre de 20 ml
- Marketing authorisation holder
- ASPEN PHARMA TRADING (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Mar 1983
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- For professional use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61100093CIP75509412CIP133400955094128Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE LIDOCAÏNE ANHYDREsolution | 50 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.